» Articles » PMID: 19035406

Improved Workup for Glycosaminoglycan Disaccharide Analysis Using CE with LIF Detection

Overview
Journal Electrophoresis
Specialty Chemistry
Date 2008 Nov 28
PMID 19035406
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

This work describes improved workup and instrumental conditions to enable robust, sensitive glycosaminoglycan (GAG) disaccharide analysis from complex biological samples. In the process of applying CE with LIF to GAG disaccharide analysis in biological samples, we have made improvements to existing methods. These include (i) optimization of reductive amination conditions, (ii) improvement in sensitivity through the use of a cellulose cleanup procedure for the derivatization, and (iii) optimization of separation conditions for robustness and reproducibility. The improved method enables analysis of disaccharide quantities as low as 1 pmol prior to derivatization. Biological GAG samples were exhaustively digested using lyase enzymes, the disaccharide products and standards were derivatized with the fluorophore 2-aminoacridone and subjected to reversed polarity CE-LIF detection. These conditions resolved all known chondroitin sulfate (CS) disaccharides or 11 of 12 standard heparin/heparan sulfate disaccharides, using 50 mM phosphate buffer, pH 3.5, and reversed polarity at 30 kV with 0.3 psi pressure. Relative standard deviation in migration times of CS ranged from 0.1 to 2.0% over 60 days, and the relative standard deviations of peak areas were less than 3.2%, suggesting that the method is reproducible and precise. The CS disaccharide compositions are similar to those obtained by our group using tandem MS. The reversed polarity CE-LIF disaccharide analysis protocol yields baseline resolution and quantification of heparin/heparan sulfate and CS/dermatan sulfate disaccharides from both standard preparations and biologically relevant proteoglycan samples. The improved CE-LIF method enables disaccharide quantification of biologically relevant proteoglycans from small samples of intact tissue.

Citing Articles

Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review.

Pepi L, Sanderson P, Stickney M, Jonathan Amster I Mol Cell Proteomics. 2020; 20:100025.

PMID: 32938749 PMC: 8724624. DOI: 10.1074/mcp.R120.002267.


Online Capillary Zone Electrophoresis Negative Electron Transfer Dissociation Tandem Mass Spectrometry of Glycosaminoglycan Mixtures.

Stickney M, Sanderson P, Leach 3rd F, Zhang F, Linhardt R, Jonathan Amster I Int J Mass Spectrom. 2020; 445.

PMID: 32641905 PMC: 7343235. DOI: 10.1016/j.ijms.2019.116209.


Analysis of Glycosaminoglycans Using Mass Spectrometry.

Staples G, Zaia J Curr Proteomics. 2015; 8(4):325-336.

PMID: 25705143 PMC: 4334465. DOI: 10.2174/157016411798220871.


Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction.

Huang Y, Mao Y, Zong C, Lin C, Boons G, Zaia J Anal Chem. 2014; 87(1):592-600.

PMID: 25486437 PMC: 4287833. DOI: 10.1021/ac503248k.


Recent advances in cellular glycomic analyses.

Furukawa J, Fujitani N, Shinohara Y Biomolecules. 2014; 3(1):198-225.

PMID: 24970165 PMC: 4030886. DOI: 10.3390/biom3010198.


References
1.
Fransson L, Roden L . Structure of dermatan sulfate. II. Characterization of products obtained by hyaluronidase digestion of dermatan sulfate. J Biol Chem. 1967; 242(18):4170-5. View

2.
Kraemer P . Heparan sulfates of cultured cells. II. Acid-soluble and -precipitable species of different cell lines. Biochemistry. 1971; 10(8):1445-51. DOI: 10.1021/bi00784a027. View

3.
Karamanos N, Syrokou A, Vanky P, Nurminen M, Hjerpe A . Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal Biochem. 1994; 221(1):189-99. DOI: 10.1006/abio.1994.1396. View

4.
David G, Bernfield M . The emerging roles of cell surface heparan sulfate proteoglycans. Matrix Biol. 1999; 17(7):461-3. DOI: 10.1016/s0945-053x(98)90092-0. View

5.
Zamfir A, Peter-Katalinic J . Capillary electrophoresis-mass spectrometry for glycoscreening in biomedical research. Electrophoresis. 2004; 25(13):1949-1963. DOI: 10.1002/elps.200405825. View